Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03194711 · ClinicalTrials.gov registry record
BVS-OCT Imaging Study
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 40
- Enrollment target
NCT03194711: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT03194711 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03194711 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The single center retrospective study evaluates the acute and long term outcomes of bioabsorbable drug-eluting scaffolds (BVS) implantation in 50 consecutive coronary artery disease (CAD) patients using optical coherence tomography (OCT) imaging.
Primary Outcome
Acute lumen gain after BVS implantation by quantitative coronary angiography (QCA)
Interventions
- DEVICE BVS implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-05-30 |
| Est. Completion | 2018-04-17 |
What the finished NCT03194711 record still lists
NCT03194711 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which BVS implantation is the first listed.
NCT03194711 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03194711 about?
NCT03194711 is a clinical study titled "BVS-OCT Imaging Study". The single center retrospective study evaluates the acute and long term outcomes of bioabsorbable drug-eluting scaffolds (BVS) implantation in 50 consecutive coronary artery disease (CAD) patients using optical coherence tomography (OCT) imaging.
What is the current status of trial NCT03194711?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2017-05-30. Estimated completion is 2018-04-17.
What interventions are being tested in trial NCT03194711?
The interventions under investigation include: BVS implantation (DEVICE).
Who is sponsoring clinical trial NCT03194711?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI